Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
TRYNGOLZA Revenue	107.50M	-
DAWNZERA Revenue	7.80M	-
Total Product Revenue	115.30M	-
SPINRAZA Royalties Revenue	212.30M	216.10M
SPINRAZA Royalties Revenue Growth	-1.76%	-10.11%
WAINUA Royalties Revenue	49.10M	20.20M
WAINUA Royalties Revenue Growth	143.07%	-
TEGSEDI and WAYLIVRA Revenue	35.00M	34.20M
TEGSEDI and WAYLIVRA Revenue Growth	2.34%	-2.01%
Commercial Licensing and Other Royalty Revenue	24.10M	22.60M
Commercial Licensing and Other Royalty Revenue Growth	6.64%	-32.13%
Total Commercial Revenue	435.80M	293.10M
Total Commercial Revenue Growth	48.69%	-5.02%
Amortization from Upfront Payments Revenue	-	131.40M
Amortization from Upfront Payments Revenue Growth	-	4.87%
Milestone Payments Revenue	-	106.40M
Milestone Payments Revenue Growth	-	5.87%
R&D License Fees Revenue	-	71.30M
R&D License Fees Revenue Growth	-	-38.95%
Other R&D Services Revenue	-	23.50M
Other R&D Services Revenue Growth	-	135.00%
Collaborative Agreement Revenue	465.80M	332.60M
Collaborative Agreement Revenue Growth	40.05%	-5.67%
Eplontersen Joint Development Revenue	42.10M	79.40M
Eplontersen Joint Development Revenue Growth	-46.98%	-37.18%
Total R&D Revenue	507.90M	412.00M
Total R&D Revenue Growth	23.28%	-13.99%
Revenue (Other)	-672.29M	-432.16M
Revenue (Total)	943.71M	705.14M
Revenue (Total) Growth	33.83%	-10.47%

Updated Feb 25, 2026. Data Source: Fiscal.ai.